Found 8 resultsAuthor Title [ Type] Year
Filters: First Letter Of Title is C and Author is Wolff, M [Clear All Filters]
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers. J Infect Dis, 180(2), 290-8. presented at the 1999 Aug. doi:10.1086/314895. (1999).
A case-control-study of risk factors for homophiles influenza Type B disease in Navajo children. AM J Trop Med Hug, 60, 263-6. presented at the 1999.. (1999).
Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children. Pediatr Infect Dis J, 33, 865-871. presented at the 08/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25222307. (2014).
Comparison of the Immunogenicity and Safety of a Split-Virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal and Intramuscular Route in Healthy Adults. Vaccine, 29, 5666-5674. presented at the 08/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21699951. (2011).
Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. J Infect Dis, 181(2), 725-8. presented at the 2000 Feb. doi:10.1086/315246. (2000).
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis, 181(3), 1133-7. presented at the 2000 Mar. doi:10.1086/315323. (2000).
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infec Dis, 181, 11133-7. presented at the 2000.. (2000).